Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Stupp

Showing results (11-20 of 313) with videos related to

Pageof 32
Sort By:
Current Opinion in Neurology|September 30, 2009
Primetime for antiangiogenic therapyGhazaleh Tabatabai, Roger Stupp
Current Opinion in Neurology|October 12, 2011
Clinical trials in neuro-oncology: one step forward, two steps back?Michael Weller, Roger Stupp
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2019
Overcoming the Blood-Brain Barrier with an Implantable Ultrasound DeviceAdam M Sonabend, Roger Stupp
Neurology|April 21, 2010
Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastomaAndrea O Rossetti, Roger Stupp
Onkologie|June 4, 2005
The role of radio- and chemotherapy in glioblastomaRoger Stupp, Damien C Weber
Nature Biotechnology|February 9, 2007
Targeting brain-tumor stem cellsRoger Stupp, Monika E Hegi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Methylguanine methyltransferase testing in glioblastoma: when and how?Roger Stupp, Monika E Hegi
The Lancet. Neurology|December 15, 2006
Neuro-oncology: oligodendroglioma and molecular markersRoger Stupp, Monika E Hegi
Current Opinion in Neurology|August 25, 2010
Epilepsy in brain tumor patientsAndrea O Rossetti, Roger Stupp
Neuro-Oncology|September 17, 2015
Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?Monika E Hegi, Roger Stupp
Pageof 32

Showing results (11-20 of 313) with videos related to

Sort By:
Pageof 32
Current Opinion in Neurology|September 30, 2009
Primetime for antiangiogenic therapyGhazaleh Tabatabai, Roger Stupp
Current Opinion in Neurology|October 12, 2011
Clinical trials in neuro-oncology: one step forward, two steps back?Michael Weller, Roger Stupp
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2019
Overcoming the Blood-Brain Barrier with an Implantable Ultrasound DeviceAdam M Sonabend, Roger Stupp
Neurology|April 21, 2010
Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastomaAndrea O Rossetti, Roger Stupp
Onkologie|June 4, 2005
The role of radio- and chemotherapy in glioblastomaRoger Stupp, Damien C Weber
Nature Biotechnology|February 9, 2007
Targeting brain-tumor stem cellsRoger Stupp, Monika E Hegi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Methylguanine methyltransferase testing in glioblastoma: when and how?Roger Stupp, Monika E Hegi
The Lancet. Neurology|December 15, 2006
Neuro-oncology: oligodendroglioma and molecular markersRoger Stupp, Monika E Hegi
Current Opinion in Neurology|August 25, 2010
Epilepsy in brain tumor patientsAndrea O Rossetti, Roger Stupp
Neuro-Oncology|September 17, 2015
Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?Monika E Hegi, Roger Stupp
Pageof 32